Literature DB >> 1675190

Hodgkin's disease presenting with the histological features of Castleman's disease.

P R Maheswaran1, A D Ramsay, A J Norton, W R Roche.   

Abstract

Three cases are reported in which an initial diagnosis of the plasma cell variant of Castleman's disease was made, but in which a second lymph node biopsy within a year showed evidence of Hodgkin's disease. Review of the initial biopsy indicated that atypical CD15 and CD30 positive cells were present in the initial biopsy. This illustrates the difficulty in making the diagnosis of Castleman's disease and suggests that the lymphoid reaction to the presence of Hodgkin's disease may result in similar histological appearances. The need for re-evaluation of the diagnosis of Castleman's disease in the face of persistent or recurrent disease is stressed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675190     DOI: 10.1111/j.1365-2559.1991.tb00833.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's disease.

Authors:  S M Hsu; S S Xie; P L Hsu; J A Waldron
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

2.  Diagnostic issues in a case of hodgkin lymphoma with castleman like features.

Authors:  Suganya K Reddy; Jinkala Sree Rekha; Sajini Elizabeth Jacob; Debdatta Basu
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-04       Impact factor: 0.900

Review 3.  Castleman's disease--a two compartment model of HHV8 infection.

Authors:  Klaus-Martin Schulte; Nadia Talat
Journal:  Nat Rev Clin Oncol       Date:  2010-07-06       Impact factor: 66.675

Review 4.  Hodgkin's lymphoma: the pathologist's viewpoint.

Authors:  S A Pileri; S Ascani; L Leoncini; E Sabattini; P L Zinzani; P P Piccaluga; A Pileri; M Giunti; B Falini; G B Bolis; H Stein
Journal:  J Clin Pathol       Date:  2002-03       Impact factor: 3.411

5.  Three patients with both Hodgkin's lymphoma and Castleman's disease: Clinicopathologic correlations and lack of association with HHV-8.

Authors:  Saadiya Haque; Robert van Kirk
Journal:  Indian J Med Paediatr Oncol       Date:  2009-04

Review 6.  [Lymphadenopathy: demarcation to malignant lymphomas].

Authors:  A C Feller
Journal:  Pathologe       Date:  2013-05       Impact factor: 1.011

7.  IL-6-positive classical Hodgkin's lymphoma co-occurring with plasma cell type of Castleman's disease: report of a case.

Authors:  Akihito Momoi; Masaru Kojima; Takeshi Sakai; Junya Ajiro; Noriatsu Isahai; Kouichi Nagai; Sadao Aoki
Journal:  Int J Hematol       Date:  2013-01-29       Impact factor: 2.490

8.  Pathobiology of hodgkin lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudio Tripodo; Francesco Bacci; Elena Sabattini; Maria Teresa Sista; Claudia Mannu; Maria Rosaria Sapienza; Maura Rossi; Maria Antonella Laginestra; Carlo A Sagramoso-Sacchetti; Simona Righi; Stefano A Pileri
Journal:  Adv Hematol       Date:  2010-12-22

9.  Persistent or recurrent Castleman's disease - Look out for a lurking lymphoma!

Authors:  Shalinee Rao; Anita Ramesh; Aarthi Rajkumar; Rekha Arcot; Sarah Kuruvilla
Journal:  Indian J Med Paediatr Oncol       Date:  2011-07

10.  International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.

Authors:  Frits van Rhee; Eric Oksenhendler; Gordan Srkalovic; Peter Voorhees; Megan Lim; Angela Dispenzieri; Makoto Ide; Sophia Parente; Stephen Schey; Matthew Streetly; Raymond Wong; David Wu; Ivan Maillard; Joshua Brandstadter; Nikhil Munshi; Wilbur Bowne; Kojo S Elenitoba-Johnson; Alexander Fössa; Mary Jo Lechowicz; Shanmuganathan Chandrakasan; Sheila K Pierson; Amy Greenway; Sunita Nasta; Kazuyuki Yoshizaki; Razelle Kurzrock; Thomas S Uldrick; Corey Casper; Amy Chadburn; David C Fajgenbaum
Journal:  Blood Adv       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.